Víctor Fernández-Dueñas
University of Barcelona
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Víctor Fernández-Dueñas.
Trends in Biotechnology | 2010
Francisco Ciruela; Jean-Pierre Vilardaga; Víctor Fernández-Dueñas
Spatiotemporal characterization of protein-protein interactions (PPIs) is essential in determining the molecular mechanisms of intracellular signaling processes. In this review, we discuss how new methodological strategies derived from non-invasive fluorescence- and luminescence-based approaches (FRET, BRET, BiFC and BiLC), when applied to the study of G protein-coupled receptor (GPCR) oligomerization, can be used to detect specific PPIs in live cells. These technologies alone or in concert with complementary methods (SRET, BRET or BiFC, and SNAP-tag or TR-FRET) can be extremely powerful approaches for PPI visualization, even between more than two proteins. Here we provide a comprehensive update on all the biotechnological aspects, including the strengths and weaknesses, of new fluorescence- and luminescence-based methodologies, with a specific focus on their application for studying PPIs.
Human Molecular Genetics | 2011
Tania López-Hernández; Sònia Sirisi; Xavier Capdevila-Nortes; Marisol Montolio; Víctor Fernández-Dueñas; Gert C. Scheper; Marjo S. van der Knaap; Pilar Casquero; Francisco Ciruela; Isidre Ferrer; Virginia Nunes; Raúl Estévez
Megalencephalic leukoencephalopathy with subcortical cysts (MLC) is a rare leukodystrophy caused by mutations in MLC1 or GLIALCAM. The GLIALCAM gene product functions as an MLC1 beta-subunit. We aim to further clarify the molecular mechanisms of MLC caused by mutations in MLC1 or GLIALCAM. For this purpose, we analyzed a human post-mortem brain obtained from an MLC patient, who was homozygous for a missense mutation (S69L) in MLC1. We showed that this mutation affects the stability of MLC1 in vitro and reduces MLC1 protein levels in the brain to almost undetectable. However, the amount of GlialCAM and its localization were nearly unaffected, indicating that MLC1 is not necessary for GlialCAM expression or targeting. These findings were supported by experiments in primary astrocytes and in heterologous cells. In addition, we demonstrated that MLC1 and GlialCAM form homo- and hetero-complexes and that MLC-causing mutations in GLIALCAM mainly reduce the formation of GlialCAM homo-complexes, leading to a defect in the trafficking of GlialCAM alone to cell junctions. GLIALCAM mutations also affect the trafficking of its associated molecule MLC1, explaining why GLIALCAM and MLC1 mutations lead to the same disease: MLC.
Biochimica et Biophysica Acta | 2010
Francisco Ciruela; Catarina Albergaria; Aroa Soriano; Laura Cuffí; Lourdes Carbonell; Silvia Sánchez; Jorge Gandía; Víctor Fernández-Dueñas
Adenosine is a well known neuromodulator in the central nervous system. As a consequence, adenosine can be beneficial in certain disorders and adenosine receptors will be potential targets for therapy in a variety of diseases. Adenosine receptors are G protein-coupled receptors, and are also expressed in a large variety of cells and tissues. Using these receptors as a paradigm of G protein-coupled receptors, the present review focus on how protein-protein interactions might contribute to neurotransmitter/neuromodulator regulation, based on the fact that accessory proteins impinge on the receptor/G protein interaction and therefore modulate receptor functioning. Besides affecting receptor signaling, these accessory components also play a key role in receptor trafficking, internalization and desensitization, as it will be reviewed here. In conclusion, the finding of an increasing number of adenosine receptors interacting proteins, and specially the molecular and functional integration of these accessory proteins into receptorsomes, will open new perspectives in the understanding of particular disorders where these receptors have been proved to be involved.
Biochimica et Biophysica Acta | 2011
Francisco Ciruela; Maricel Gómez-Soler; Diego Guidolin; Dasiel O. Borroto-Escuela; Luigi F. Agnati; Kjell Fuxe; Víctor Fernández-Dueñas
While the G protein-coupled receptor (GPCR) oligomerization has been questioned during the last fifteen years, the existence of a multi-receptor complex involving direct receptor-receptor interactions, called receptor oligomers, begins to be widely accepted. Eventually, it has been postulated that oligomers constitute a distinct functional form of the GPCRs with essential receptorial features. Also, it has been proven, under certain circumstances, that the GPCR oligomerization phenomenon is crucial for the receptor biosynthesis, maturation, trafficking, plasma membrane diffusion, and pharmacology and signalling. Adenosine receptors are GPCRs that mediate the physiological functions of adenosine and indeed these receptors do also oligomerize. Accordingly, adenosine receptor oligomers may improve the molecular mechanism by which extracellular adenosine signals are transferred to the G proteins in the process of receptor transduction. Importantly, these adenosine receptor-containing oligomers may allow not only the control of the adenosinergic function but also the fine-tuning modulation of other neurotransmitter systems (i.e. dopaminergic and glutamatergic transmission). Overall, we underscore here recent significant developments based on adenosine receptor oligomerization that are essential for acquiring a better understanding of neurotransmission in the central nervous system under normal and pathological conditions.
Journal of the American Chemical Society | 2015
Vanessa Soto-Cerrato; Pilar Manuel-Manresa; Elsa Hernando; Silvia Calabuig-Fariñas; Alicia Martínez-Romero; Víctor Fernández-Dueñas; Kristoffer Sahlholm; Thomas Knöpfel; María García-Valverde; Ananda M. Rodilla; Eloisa Jantus-Lewintre; Rosa Farràs; Francisco Ciruela; Ricardo Pérez-Tomás; Roberto Quesada
Facilitated anion transport potentially represents a powerful tool to modulate various cellular functions. However, research into the biological effects of small molecule anionophores is still at an early stage. Here we have used two potent anionophore molecules inspired in the structure of marine metabolites tambjamines to gain insight into the effect induced by these compounds at the cellular level. We show how active anionophores, capable of facilitating the transmembrane transport of chloride and bicarbonate in model phospholipid liposomes, induce acidification of the cytosol and hyperpolarization of plasma cell membranes. We demonstrate how this combined effect can be used against cancer stem cells (CSCs). Hyperpolarization of cell membrane induces cell differentiation and loss of stemness of CSCs leading to effective elimination of this cancer cell subpopulation.
European Journal of Neuroscience | 2010
Francisco Ciruela; Víctor Fernández-Dueñas; Kristoffer Sahlholm; Laura Fernández-Alacid; Joel C. Nicolau; Masahiko Watanabe; Rafael Luján
The stimulation of inhibitory neurotransmitter receptors, such as γ‐aminobutyric acid type B (GABAB) receptors, activates G protein‐gated inwardly‐rectifying K+ (GIRK) channels, which influence membrane excitability. There is now evidence suggesting that G protein‐coupled receptors and G protein‐gated inwardly‐rectifying K+ [GIRK/family 3 of inwardly‐rectifying K+ (Kir3)] channels do not diffuse freely within the plasma membrane, but instead there are direct protein–protein interactions between them. Here, we used bioluminescence resonance energy transfer, co‐immunoprecipitation, confocal and electron microscopy techniques to investigate the oligomerization of GABAB receptors with GIRK channels containing the GIRK3 subunit, whose contribution to functional channels is still unresolved. Co‐expression of GABAB receptors and GIRK channels in human embryonic kidney‐293 cells in combination with co‐immunoprecipitation experiments established that the metabotropic receptor forms stable complexes with GIRK channels. Using bioluminescence resonance energy transfer, we have shown that, in living cells under physiological conditions, GABAB receptors interact directly with GIRK1/GIRK3 heterotetramers. In addition, we have provided evidence that the receptor–effector complexes are also found in vivo and identified that the cerebellar granule cells are one neuron population where the interaction probably takes place. Altogether, our data show that signalling complexes containing GABAB receptors and GIRK channels are formed shortly after biosynthesis, probably in the endoplasmic reticulum and/or endoplasmic reticulum/Golgi apparatus complex, suggesting that this might be a general feature of receptor–effector ion channel signal transduction and supporting a channel‐forming role for the GIRK3 subunit.
Journal of Neurochemistry | 2012
Víctor Fernández-Dueñas; Maricel Gómez-Soler; Kenneth A. Jacobson; Santhosh T. Kumar; Kjell Fuxe; Dasiel O. Borroto-Escuela; Francisco Ciruela
In the CNS, an antagonistic interaction has been shown between adenosine A2A and dopamine D2 receptors (A2ARs and D2Rs) that may be relevant both in normal and pathological conditions (i.e., Parkinsons disease). Thus, the molecular determinants mediating this receptor–receptor interaction have recently been explored, as the fine tuning of this target (namely the A2AR/D2R oligomer) could possibly improve the treatment of certain CNS diseases. Here, we used a fluorescence resonance energy transfer‐based approach to examine the allosteric modulation of the D2R within the A2AR/D2R oligomer and the dependence of this receptor–receptor interaction on two regions rich in positive charges on intracellular loop 3 of the D2R. Interestingly, we observed a negative allosteric effect of the D2R agonist quinpirole on A2AR ligand binding and activation. However, these allosteric effects were abolished upon mutation of specific arginine residues (217–222 and 267–269) on intracellular loop 3 of the D2R, thus demonstrating a major role of these positively charged residues in mediating the observed receptor–receptor interaction. Overall, these results provide structural insights to better understand the functioning of the A2AR/D2R oligomer in living cells.
Methods | 2012
Víctor Fernández-Dueñas; Javier Llorente; Jorge Gandía; Dasiel O. Borroto-Escuela; Luigi F. Agnati; Carla I. Tasca; Kjell Fuxe; Francisco Ciruela
Understanding of the molecular mechanisms of protein-protein interactions (PPIs) at the cell surface of living cells is fundamental to comprehend the functional meaning of a large number of cellular processes. Here we discuss how new methodological strategies derived from non-invasive fluorescence-based approaches (i.e. fluorescence resonance energy transfer, FRET) have been successfully developed to characterize plasma membrane PPIs. Importantly, these technologies alone - or in concert with complementary methods (i.e. SNAP-tag/TR-FRET, TIRF/FRET) - can become extremely powerful approaches for visualizing cell surface PPIs, even between more than two proteins and also in native tissues. Interestingly, these methods would also be relevant in drug discovery in order to develop new high-throughput screening approaches or to identify new therapeutic targets. Accordingly, herein we provide a thorough assessment on all biotechnological aspects, including strengths and weaknesses, of these fluorescence-based methodologies when applied in the study of PPIs occurring at the cell surface of living cells.
Disease Models & Mechanisms | 2015
Víctor Fernández-Dueñas; Jaume Taura; Martin Cottet; Maricel Gómez-Soler; Marc López-Cano; Catherine Ledent; Masahiko Watanabe; Eric Trinquet; Jean-Philippe Pin; Rafael Luján; Thierry Durroux; Francisco Ciruela
Parkinson’s disease (PD) is a dopaminergic-related pathology in which functioning of the basal ganglia is altered. It has been postulated that a direct receptor-receptor interaction – i.e. of dopamine D2 receptor (D2R) with adenosine A2A receptor (A2AR) (forming D2R-A2AR oligomers) – finely regulates this brain area. Accordingly, elucidating whether the pathology prompts changes to these complexes could provide valuable information for the design of new PD therapies. Here, we first resolved a long-standing question concerning whether D2R-A2AR assembly occurs in native tissue: by means of different complementary experimental approaches (i.e. immunoelectron microscopy, proximity ligation assay and TR-FRET), we unambiguously identified native D2R-A2AR oligomers in rat striatum. Subsequently, we determined that, under pathological conditions (i.e. in a rat PD model), D2R-A2AR interaction was impaired. Collectively, these results provide definitive evidence for alteration of native D2R-A2AR oligomers in experimental parkinsonism, thus conferring the rationale for appropriate oligomer-based PD treatments.
Biophysical Journal | 2016
Héctor Gaitán-Peñas; Antonella Gradogna; Lara Laparra-Cuervo; Carles Solsona; Víctor Fernández-Dueñas; Alejandro Barrallo-Gimeno; Francisco Ciruela; Melike Lakadamyali; Michael Pusch; Raúl Estévez
Volume-regulated anion channels (VRACs) play an important role in controlling cell volume by opening upon cell swelling. Recent work has shown that heteromers of LRRC8A with other LRRC8 members (B, C, D, and E) form the VRAC. Here, we used Xenopus oocytes as a simple system to study LRRC8 proteins. We discovered that adding fluorescent proteins to the C-terminus resulted in constitutive anion channel activity. Using these constructs, we reproduced previous findings indicating that LRRC8 heteromers mediate anion and osmolyte flux with subunit-dependent kinetics and selectivity. Additionally, we found that LRRC8 heteromers mediate glutamate and ATP flux and that the inhibitor carbenoxolone acts from the extracellular side, binding to probably more than one site. Our results also suggest that the stoichiometry of LRRC8 heteromers is variable, with a number of subunits ≥6, and that the heteromer composition depends on the relative expression of different subunits. The system described here enables easy structure-function analysis of LRRC8 proteins.